-
11 Stocks Breaking Down
Monday, July 11, 2011 - 2:25pm | 266The stocks below are showing signs of, or already in the process of, breaking down as the smart money appears to be leaving them in a subtle manner. There are stocks trading at its peak and finally showing some vulnerability, while on the other extreme, there are stocks that have been in a channel...
-
Options Brief: Arena Pharmaceuticals
Monday, July 11, 2011 - 1:17pm | 85Shares of Arena Pharmaceuticals (NASDAQ: ARNA) are lower on the session by 1.98%, trading at $1.48. Overall call volume is now running at 2.48x the daily average, with 60% of all calls traded being purchases on the offer. 1,427 contracts have traded on the session so far. Arena Pharmaceuticals,...
-
J.P. Morgan Maintains Neutral On Biogen Idec Following MS Data
Monday, July 11, 2011 - 1:12pm | 214J.P. Morgan Chase & Co. is maintaining its Neutral rating on shares of Biogen Idec (NASDAQ: BIIB). In a note to clients, J.P. Morgan Chase & Co. writes, "This morning Sanofi (Covered by JPM European Healthcare analyst Alexandra Hauber) announced top-line data from the phase 3 CARE-MS 1...
-
Calls Purchased on PDL BioPharma
Monday, July 11, 2011 - 12:48pm | 115Shares of PDL BioPharma (NASDAQ: PDLI) are higher on the session by 7.48%, currently trading at $6.18. The stock has been moving largely lower over the past two months, though it is currently trading above the 50-day moving average. Options traders are buying calls on the name today. Though action...
-
PDL BioPharma Trading Over 7% Higher After Patent Ruling
Monday, July 11, 2011 - 12:47pm | 148PDL BioPharma (NASDAQ: PDLI) announced a favorable ruling today, specifically, that on July 7, 2011, the Second Judicial District Court of Nevada ruled in favor of PDL on two motions to dismiss filed by Genentech and F. Hoffmann LaRoche, Ltd. (Roche) in PDL's lawsuit related to the 2003 settlement...
-
Poniard Pharmaceuticals Adjourns Reconvened Annual Meeting of Shareholders to Solicit Additional Proxies for Important Reverse Stock Split Proposal
Monday, July 11, 2011 - 11:51am | 179Poniard Pharmaceuticals, Inc. (NASDAQ: PARD) announced today that it reconvened its annual meeting of shareholders on July 8, 2011 and adjourned the meeting until 9:00 a.m. Pacific Time, on July 22, 2011, to solicit additional proxies to vote in favor of a proposal authorizing the Company's Board...
-
NASDAQ Stocks Hitting 52-Week Highs
Monday, July 11, 2011 - 10:22am | 125Susser Holdings Corporation (NASDAQ: SUSS) shares rose 4.36% to create a new 52-week high of $18.33. SUSS' trailing-twelve-month revenue is $4.16 billion. Peet's Coffee & Tea Inc (NASDAQ: PEET) shares gained 1.05% to create a new 52-week high of $62.66. PEET had no debt for the recent quarter...
-
Options Brief: Pharmacyclics
Monday, July 11, 2011 - 10:13am | 73Shares of Pharmacyclics (NASDAQ: PCYC) are lower on the session by 1.47%, trading at $11.37. Overall call volume is now running at 7.17x the daily average, with 9% of all calls traded being purchases on the offer. 4,731 contracts have traded on the session so far. Pharmacyclics Inc. is a...
-
Rodman & Renshaw Reiterates Market Perform on MannKind
Monday, July 11, 2011 - 8:55am | 26Rodman & Renshaw reiterated its Market Perform rating on MannKind (NASDAQ: MNKD). On Friday, MNKD closed the day at $3.86.
-
Benzinga's Top Pre-Market NASDAQ Gainers
Monday, July 11, 2011 - 8:46am | 123Kandi Technolgies Corp (NASDAQ: KNDI) shares advanced 12.03% to $2.05 in the pre-market session. KNDI signed a strategic cooperation agreement with Hangzhou Electric Vehicle Service Co Ltd. Micromet Inc (NASDAQ: MITI) shares advanced 5.21% to $6.06 in the pre-market session. MITI entered into a...
-
Goldman Sachs Resumes Coverage On Onyx Pharmaceuticals
Monday, July 11, 2011 - 8:19am | 166Goldman Sachs is resuming coverage on shares of Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) with a Neutral rating and a $40 price target. In a note to clients, Goldman Sachs writes, "We are resuming coverage of ONXX with a Neutral rating and a $40, 12-month price target. The company is on the verge...
-
Benzinga's Top Pre-Market NASDAQ Gainers
Monday, July 11, 2011 - 8:15am | 123Kandi Technolgies Corp (NASDAQ: KNDI) shares advanced 12.03% to $2.05 in the pre-market session. KNDI signed a strategic cooperation agreement with Hangzhou Electric Vehicle Service Co Ltd. Micromet Inc (NASDAQ: MITI) shares advanced 5.21% to $6.06 in the pre-market session. MITI entered into a...
-
Bank Of America Updates Achillion Pharmaceuticals Model
Monday, July 11, 2011 - 8:13am | 87According to Bank of America, Achillion Pharmaceuticals (NASDAQ: ACHN) model was updated based on ACHN's equity offering. Bank of America said that ACHN's 11M share offering raised a net of $60.9M. “We reiterate our Buy rating and $11 PO based on upcoming data catalysts by year end: 1) Protease...
-
Alnylam Files Clinical Trial Application for ALN-PCS, an RNAi Therapeutic Targeting PCSK9 for the Treatment of Severe Hypercholesterolemia
Monday, July 11, 2011 - 8:06am | 246Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today that it has filed a Clinical Trial Application with the Medicines and Healthcare products Regulatory Agency to initiate a Phase I clinical trial with ALN-PCS, an RNAi therapeutic for the treatment of severe hypercholesterolemia. Upon...
-
A Peek Into The Market Before The Trading Starts
Monday, July 11, 2011 - 7:57am | 374Pre-open movers US stock futures are lower this morning, as debt fears moved to Italy. Futures on the Dow Jones Industrial Average dropped 102 points to 12,513.00 and futures on the S&P 500 stock index fell 14.70 points to 1,327.10. Nasdaq 100 futures declined 27.00 points to 2,381.50. A Peek...